No Detail Found!

Effects of intravenous bolus injection of emulsified Isoflurane on QTc interval of healthy volunteers in pharmacokinetics study.

Author(s)
Rong Liu Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
Yan Li Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
Jin Liu Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China;Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, China
Wen-Sheng Zhang Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China;Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, China
Xiao-Qian Yi Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
Jing Xu Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
Abstract
Emulsified isoflurane is a novel intravenous anesthetic, which is a lipid emulsion of isoflurane. As some drugs have a QTc-prolongation effect which can increase a risk of arrhythmia, this study was to evaluate the effects of emulsified isoflurane on the QTc interval. This was a single-center, randomized, single-blind, non-comparative study. Subjects were randomly allocated to receive an intravenous bolus injection of 22.63, 38.26, or 49.73 mg/kg emulsified isoflurane, respectively. Standard 12-lead electrocardiograms were recorded before administration and at 28 timepoints after administration. Blood samples and the end-tidal isoflurane concentrations were collected for pharmacokinetic analysis. The primary target variable was the QTcF change from baseline at each time point. A two-sided 90% confidence interval (CI) was calculated for a QTcF change from baseline at each timepoint. The maximal 90% CIs of the mean QTcF from the baseline for 22.63, 38.26 and 49.73mg/kg emulsified isoflurane were 2.52-21.18 ms, 15.66-35.90 ms, and 17.65-40.71 ms, respectively. Non-significant relationship was observed between QTcF and the plasma concentration (or the end-tidal isoflurane concentration). Single intravenous dose of emulsified isoflurane of the anticipated therapeutic dose or supra-therapeutic doses was associated with a potential dose-dependent and nonconcentration-related QTc-prolongation effect.
Publication Details
Page(s) 1183-1189
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 27, Issue: 5, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

90

Views